Author:
Alberts D.S.,Speicher L.A.,Krutzsch M.,Wymer J.,Capizzi R.L.,Conlon J.,Barrett A.,Aickin M.
Reference12 articles.
1. Biological factors affecting the radioprotective efficiency of S-2-[3-aminopropylamino] ethylphosphorothioic acid (WR-2721): LD50(7) doses;Yuhas;Radiat Res,1971
2. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by WR-2721;Wasserman;Cancer Clin Trials,1981
3. Selective inhibition of the nephrotoxicity of cis-dichlorodiammine platinum (II) by WR-2721 without altering its antitumour properties;Yuhas;Cancer Treat Rep,1980
4. Time dependence of the selective modulation of cisplatin-induced nephrotoxity by WR-2721 in the mouse;Treskes;Cancer Res,1992
5. Cisplatin neuropathy: risk factors, prognosis and protection by WR-2721;Mollman;Cancer,1988
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献